Ying-qiang Shen

State Key Laboratory Of Oral Diseases
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Elucidation of the pathogenesis of peroxisome biogenesis disorders (PBDs): From molecular mechanisms to diagnosis-therapy linkages and AI-assisted potential.

Elucidation of the pathogenesis of peroxisome biogenesis disorders (PBDs): From molecular mechanisms to diagnosis-therapy linkages and AI-assisted potential.

Journal: Mutation research. Reviews in mutation research

Published: September 15, 2025

Crosstalk of glutamine metabolism between cancer-associated fibroblasts and cancer cells.

Crosstalk of glutamine metabolism between cancer-associated fibroblasts and cancer cells.

Journal: Cellular signalling

Published: April 14, 2025

Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation.

Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation.

Journal: Medical oncology (Northwood, London, England)

Published: March 28, 2025

NSD1 mutation status determines metabolic inhibitor sensitivity in head and neck squamous cell carcinomas by regulating mitochondrial respiration.

NSD1 mutation status determines metabolic inhibitor sensitivity in head and neck squamous cell carcinomas by regulating mitochondrial respiration.

Journal: The Journal of pathology

Published: December 12, 2024

GPCRs identified on mitochondrial membranes: New therapeutic targets for diseases.

GPCRs identified on mitochondrial membranes: New therapeutic targets for diseases.

Journal: Journal of pharmaceutical analysis

Published: September 10, 2024

Role of reactive oxygen species in regulating epigenetic modifications.

Role of reactive oxygen species in regulating epigenetic modifications.

Journal: Cellular signalling

Published: August 25, 2024

Bone complications of cancer treatment.

Bone complications of cancer treatment.

Journal: Cancer treatment reviews

Published: May 23, 2024

Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagy.

Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagy.

Journal: Toxicology and applied pharmacology

Published: January 03, 2024

Precision therapy targeting CAMK2 to overcome resistance to EGFR inhibitors in FAT1 -mutated oral squamous cell carcinoma.

Precision therapy targeting CAMK2 to overcome resistance to EGFR inhibitors in FAT1 -mutated oral squamous cell carcinoma.

Journal: Chinese medical journal

Published: December 15, 2023

Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases.

Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases.

Journal: Redox biology

Published: October 14, 2023

DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.

DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.

Journal: British journal of cancer

Published: May 24, 2023

Mitochondrial DNA-targeted therapy: A novel approach to combat cancer.

Mitochondrial DNA-targeted therapy: A novel approach to combat cancer.

Journal: Cell insight

Published: May 08, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026